Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $174.77M.
ENTERPRISE VALUE (EV)
$174.77M
Heron Therapeutics, Inc.
Market Cap
$62.78M
Enterprise Value (EV)
$174.77M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $62.78M | $174.77M |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | $53.40M |
| InterCure Ltd. (INCR)vs › | $63.02M | $105.87M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | $67.64M |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | $74.01M |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | $56.35M |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | $43.75M |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | $63.83M |
Market Cap
$62.78M
Total Debt
$140.64M
Cash
$28.65M
Enterprise Value
$174.77M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
